A Study to Investigate the Efficacy and Safety of a Single Injection of Corifollitropin Alfa (Organon 36286) for Ovarian Stimulation Using Daily Recombinant Follicle Stimulating Hormone (FSH) as Reference (P05787)

NCT00696800 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1509

Enrollment

INDUSTRY

Sponsor class

Conditions

In Vitro Fertilization

Interventions

DRUG: Corifollitropin alfa
BIOLOGICAL: RecFSH / Follitropin beta (Days 1 to 7)
DRUG: Placebo Corifollitropin alfa
DRUG: Placebo RecFSH / follitropin beta
BIOLOGICAL: RecFSH / Follitropin beta (Days 8 to hCG)
DRUG: Ganirelix
BIOLOGICAL: hCG
BIOLOGICAL: Progesterone

Sponsor

Organon and Co